We are live on ! Find out more
NRC

North Run Capital Portfolio holdings

AUM $43.5M
1-Year Est. Return 38.24%
This Fund
S&P 500
This Quarter Est. Return
-11.06%
1 Year Est. Return
-38.24%
3 Year Est. Return
+19.43%
5 Year Est. Return
+17.57%
10 Year Est. Return
–
AUM
$327M
AUM Growth
-$309M
Cap. Flow
-$261M
Cap. Flow %
-79.8%
Top 10 Hldgs %
87%
Holding
28
New
1
Increased
4
Reduced
13
Closed
9

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$10.2M
2
WTW icon
Willis Towers Watson
WTW
+$9.08M
3
NOMD icon
Nomad Foods
NOMD
+$3.28M
4
IMPV
Imperva, Inc.
IMPV
+$2.77M
5
CACQ
Caesars Acquisition Company
CACQ
+$705K

Top Sells

Rank Stock Value
1
PRGO icon
Perrigo
PRGO
+$40.6M
2
ESL
Esterline Technologies
ESL
+$34.2M
3
DBRG icon
DigitalBridge
DBRG
+$27.9M
4
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
+$27.4M
5
RP
RealPage, Inc.
RP
+$25.4M

Sector Composition

Rank Sector Weight
1 Healthcare 48.09%
2 Financials 15.89%
3 Materials 10.97%
4 Technology 8.96%
5 Consumer Discretionary 6.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BKD icon
1
Brookdale Senior Living
BKD
$3.49B
$42.7M 13.05%
3,440,000
-460,000
-12% -$6.18M
ELV icon
2
Elevance Health
ELV
$81.5B
$39.5M 12.07%
275,000
-60,000
-18% -$8.03M
TEVA icon
3
Teva Pharmaceuticals
TEVA
$40.8B
$38.8M 11.85%
1,070,000
+255,000
+31% +$10.2M
CSTM icon
4
Constellium
CSTM
$3.76B
$35.9M 10.97%
6,090,000
-1,265,000
-17% -$7.73M
MCK icon
5
McKesson
MCK
$100B
$33M 10.08%
235,000
-15,000
-6% -$2.21M
WTW icon
6
Willis Towers Watson
WTW
$31.2B
$30.9M 9.45%
252,950
+72,850
+40% +$9.08M
MX icon
7
Magnachip Semiconductor
MX
$119M
$21.1M 6.44%
3,400,000
– –
TFCFA
8
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$19.8M 6.04%
705,000
-1,020,000
-59% -$27.4M
CROX icon
9
Crocs
CROX
$6.14B
$13M 3.98%
1,900,000
-75,000
-4% -$582K
NOMD icon
10
Nomad Foods
NOMD
$1.66B
$10.1M 3.08%
1,055,000
+300,000
+40% +$3.28M
DBRG icon
11
DigitalBridge
DBRG
$2.93B
$9.7M 2.96%
162,500
-493,750
-75% -$27.9M
NWY
12
DELISTED
New York & Co Inc
NWY
$8.1M 2.47%
3,567,880
-394,257
-10% -$860K
SCU
13
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$7.61M 2.32%
230,000
-120,000
-34% -$3.83M
EVTC icon
14
Evertec
EVTC
$1.88B
$5.64M 1.72%
317,695
-507,305
-61% -$8.4M
NSM
15
DELISTED
Nationstar Mortgage Holdings
NSM
$3.79M 1.16%
210,000
-790,000
-79% -$13M
IMPV
16
DELISTED
Imperva, Inc.
IMPV
$2.62M 0.8%
+68,228
New +$2.77M
ALIM
17
DELISTED
Alimera Sciences
ALIM
$1.87M 0.57%
115,333
-117,807
-51% -$2.16M
CACQ
18
DELISTED
Caesars Acquisition Company
CACQ
$1.68M 0.51%
124,773
+57,933
+87% +$705K
EYPT icon
19
EyePoint Inc
EYPT
$1.03B
$1.54M 0.47%
90,000
-77,492
-46% -$1.57M
CFG icon
20
Citizens Financial Group
CFG
$30.3B
– –
-1,025,000
Closed -$25.3M
NPO icon
21
Enpro
NPO
$6.63B
– –
-283,970
Closed -$16.1M
PRGO icon
22
Perrigo
PRGO
$1.4B
– –
-440,000
Closed -$40.6M
SBCF icon
23
Seacoast Banking Corp of Florida
SBCF
$3.36B
– –
-300,000
Closed -$4.83M
RP
24
DELISTED
RealPage, Inc.
RP
– –
-990,000
Closed -$25.4M
AMAG
25
DELISTED
AMAG Pharmaceuticals
AMAG
– –
-560,000
Closed -$13.7M
1
2

Similar funds

ACM
Axel Capital Management New York $47.4M AUM 2.75% 1-Year Est. Return
HA
Havens Advisors New York $39.3M AUM 80.07% 1-Year Est. Return
JI
Jeereddi Investments Los Angeles, California $38.1M AUM 12.15% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return
BGP
BrandyTrust Global Partners Hockessin, Delaware $35.4M AUM
EOCM
Energy Opportunities Capital Management Austin, Texas $34.4M AUM 54.2% 1-Year Est. Return
SJIA
St. James Investment Advisors Port Jefferson, New York $54.6M AUM 0.39% 1-Year Est. Return
LN
Lewin Nick $31.5M AUM

North Run Capital's Q4 2016 Portfolio in Review

As of Q4 2016, North Run Capital held 28 positions worth $327M, down 49% from $637M the previous quarter. Its ten largest holdings account for 87% of the portfolio.

North Run Capital withdrew a net $261M in Q4 2016, closing 9 positions and reducing 13 holdings. Its most notable exit was Perrigo, an estimated $40.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, up from 39% a quarter earlier, followed by Financials and Materials.

Against the trend, North Run Capital opened a new position in Imperva, Inc. worth $2.62M.

  • North Run Capital's largest Q4 2016 buy was Imperva, Inc.: 68,228 shares worth $2.62M.
  • North Run Capital added most to Teva Pharmaceuticals in Q4 2016, an estimated $10.2M increase.
  • North Run Capital's biggest Q4 2016 reduction was DigitalBridge, cutting an estimated $27.9M.
  • North Run Capital fully exited Perrigo in Q4 2016, selling an estimated $40.6M.
  • North Run Capital's ten largest holdings make up 87% of its $327M portfolio in Q4 2016.
  • North Run Capital opened 1 new position and closed 9 in Q4 2016.
  • North Run Capital's portfolio value fell 49% quarter-over-quarter to $327M.

Based on North Run Capital's 13F filing for Q4 2016, filed 10 Feb 2017.